Malta vs Togo: The number of people with susceptibility test result for rifampicin
Malta
93.1
in 2021
Togo
92.42
in 2021
Malta rank
59th
Togo rank
61st
The number of people with susceptibility test result for rifampicin over time
- Malta
- Togo
How they compare
Malta currently reports 93.1 against 92.42 in Togo, a difference of 0.68.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Malta ahead.
Malta ranks 59th and Togo ranks 61st of 146 countries.
Across the 2 decades both report, Malta averaged higher in 1 and Togo in 1.
Head to head by decade
| Decade | Malta | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 91.41 | 36.81 | 54.6 | Malta |
| 2020s | 90.14 | 90.74 | 0.6029 | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Malta or Togo?
- Malta, at 93.1 against 92.42 in Togo as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Malta and Togo?
- 0.68, with Malta ahead.
- How many years of comparable data are there for Malta and Togo?
- 5 years are reported by both, from 2017 to 2021.
- How do Malta and Togo rank globally for the number of people with susceptibility test result for rifampicin?
- Malta ranks 59th and Togo ranks 61st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.